TVRD
Tvardi Therapeutics
TVRD
TVRD
121 hedge funds and large institutions have $45.6M invested in Tvardi Therapeutics in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
45% less capital invested
Capital invested by funds: $83.3M → $45.6M (-$37.7M)
47% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 30
Holders
121
Holding in Top 10
–
Calls
$132K
Puts
$49K
Top Buyers
| 1 | +$1.28M | |
| 2 | +$1.09M | |
| 3 | +$708K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$436K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$422K |
Top Sellers
| 1 | -$1.79M | |
| 2 | -$1.53M | |
| 3 | -$1.01M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$618K |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$566K |